4-methoxycinnamaldehyde has been researched along with Laryngeal-Neoplasms* in 1 studies
1 other study(ies) available for 4-methoxycinnamaldehyde and Laryngeal-Neoplasms
Article | Year |
---|---|
4-Methoxycinnamaldehyde inhibited human respiratory syncytial virus in a human larynx carcinoma cell line.
4-Methoxycinnamaldehyde, an active constituent of Agastache rugosa, was examined for its cytoprotective activity against RSV by XTT method in human larynx carcinoma cell line. 4-Methoxycinnamaldehyde could effectively inhibit cytopathic effect of RSV (p<0.0001) with an estimated IC(50) of 0.055microg/ml and a selectivity index (SI) of 898.2. 4-Methoxycinnamaldehyde (0.03microg/ml) could inhibit viral entrance by interfering viral attachment (IC(50) of 0.06microg/ml; p<0.0001) and internalization (IC(50) of 0.01microg/ml; p<0.0001). 4-Methoxycinnamaldehyde significantly increased the basal production of IFN (p=0.0015), but not the virus-induced IFN production. Therefore, its cytoprotective activity against RSV was not mediated by interferon. In conclusion, 4-methoxycinnamaldehyde might be helpful to manage the disease induced by RSV infection. Topics: Acrolein; Agastache; Cell Line, Tumor; Humans; Interferons; Laryngeal Neoplasms; Phytotherapy; Plant Extracts; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Virus Attachment; Virus Internalization | 2009 |